Rare FDA Move Shows Stance On Remote Monitoring Devices

By Dominick DiSabatino, Julian Klein and Audrey Crowell · June 23, 2023, 5:58 PM EDT

On May 25, the U.S. Food and Drug Administration issued a warning letter to iRhythm Technologies Inc., citing a deluge of violations related to the company's heart-monitoring device — the Zio...

To view the full article, register now.